Why is Mankind Pharma falling/rising?

As of 09-Jul, Mankind Pharma Ltd's stock price is rising, currently at 2,525.30, reflecting an increase of 100.3 or 4.14%. The stock has shown strong performance recently, gaining 4.27% over the last two days and outperforming its sector by 3.94% today. It has also demonstrated positive returns over the past week and month, with increases of 5.88% and 7.21%, respectively. Despite a year-to-date decline of 12.22%, the stock has generated a notable return of 19.94% over the past year, significantly outperforming the broader market's return of 3.96%. The company benefits from high management efficiency, a low debt-to-equity ratio, and healthy long-term growth, with operating profit increasing at an annual rate of 23.44%. However, it faces challenges due to negative results in March 2025, which have raised concerns about its valuation and profitability.
In the broader market context, Mankind Pharma's recent performance has been strong compared to the benchmark, as it has outperformed the Sensex, which only saw a 0.15% increase over the past week. The stock's liquidity remains adequate for trading, although there has been a significant drop in investor participation, with delivery volume falling by 72.57% against the five-day average. This decline in participation could indicate potential caution among investors despite the stock's recent gains. Overall, while Mankind Pharma has shown resilience and positive performance metrics, the mixed signals from its financial results and investor activity suggest a complex landscape for its future price movements.